Lancaster, PA, United States of America

Ashvin V Gavai

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashvin V Gavai. Retrieved from https://idiyas.com/inventor/ashvin-v-gavai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ashvin V Gavai: Innovator in Pharmaceutical Chemistry

Introduction

Ashvin V Gavai is a notable inventor based in Lancaster, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as valuable therapeutic agents.

Latest Patents

Gavai holds a patent for "Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene." This invention relates to certain quinolinyl-benzoheterobicyclic compounds and their use as valuable pharmaceutical agents. These compounds are particularly recognized for their role as lipoxygenase inhibitors and/or leukotriene antagonists, as well as mediator release inhibitors that are useful as anti-inflammatory and anti-allergic agents. He has 1 patent to his name.

Career Highlights

Ashvin V Gavai is associated with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has been instrumental in advancing research and development in pharmaceutical innovations. His work has contributed to the understanding and treatment of various inflammatory and allergic conditions.

Collaborations

Some of his notable coworkers include Fu-Chih Huang and Keith S Learn, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Ashvin V Gavai's contributions to pharmaceutical chemistry highlight his innovative spirit and dedication to improving health outcomes through scientific research. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…